US3893278A - Method of manufacturing capsules containing gaseous radioisotope - Google Patents

Method of manufacturing capsules containing gaseous radioisotope Download PDF

Info

Publication number
US3893278A
US3893278A US388488A US38848873A US3893278A US 3893278 A US3893278 A US 3893278A US 388488 A US388488 A US 388488A US 38848873 A US38848873 A US 38848873A US 3893278 A US3893278 A US 3893278A
Authority
US
United States
Prior art keywords
radioisotope
xenon
diluent
enclosure
comprised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US388488A
Other languages
English (en)
Inventor
Robert E Lewis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Electric Co
Original Assignee
General Electric Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Electric Co filed Critical General Electric Co
Priority to US388488A priority Critical patent/US3893278A/en
Priority to AU68518/74A priority patent/AU479764B2/en
Priority to DK249574AA priority patent/DK134388B/da
Priority to DK29574*#A priority patent/DK29574A/da
Priority to GB2085574A priority patent/GB1465961A/en
Priority to NL7407235A priority patent/NL7407235A/xx
Priority to DE2434277A priority patent/DE2434277A1/de
Priority to CH1091674A priority patent/CH573748A5/xx
Priority to FR7427942A priority patent/FR2245336B1/fr
Priority to BE147543A priority patent/BE818776A/xx
Priority to JP49092430A priority patent/JPS5072479A/ja
Priority to IT26304/74A priority patent/IT1019936B/it
Priority to SE7410389A priority patent/SE409075B/xx
Application granted granted Critical
Publication of US3893278A publication Critical patent/US3893278A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1262—Capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S53/00—Package making
    • Y10S53/90—Capsules

Definitions

  • ABSTRACT A method of manufacturing capsules containing a gaseous radioisotope with a diluent is presented having the steps of (a) introducing the radioisotope and the diluent into a mixing zone, (b) mixing the radioisotope and the diluent in the mixing zone, (c) discharging the mixture into a gas impermeable enclosure, ((1) sealing the gas impermeable enclosure into segments of a selected size and (e) separating the segments into individual capsules. [t is also possible to manufacture capsules containing moisture in addition to the radioisotope-diluent mixture.
  • Radioactive isotopes of xenon and other radioisotopes are useful in the field of medicine and particularly in medical diagnosis.
  • xenon-133 in the medical field for studying blood flow in muscles, scanning the lungs for lung functional disorders (e.g., emphysema and emboli), scanning the brain and scanning for cardiac abnormalities.
  • xenon-l33 can be introduced into a human body by one of two processes. ln an inhalation process, the patient breathes a gas containing xenon-I33 and the xenon-133 is drawn directly into the patients lungs.
  • a saline solution containing dissolved xenon-l33 is injected into the blood stream of the patient and through perfusion the xenon-133 goes to various organs of the patient, including the patients lungs.
  • Radioactive gases having more optimum imaging characteristics for specific purposes may also be used, such as xenon-127.
  • One current practice of formulating a xenon-133 solution for medical applications is to dissolve the xenonl33 directly into a saline solution to achieve gas concentrations appreciably below saturation of the xenon- ]33 in the solution at the temperature of dissolution. This avoids any occurrence of bubble formation in the solution during use.
  • the present procedure used in the medical profession for preparing injectable doses of xenon-I33 as an aqueous solution involves crushing an ampoule containing xenon-l 33 in a container filled with a normal saline solution.
  • xenon-I33 The widest use of xenon-I33 is in pulmonary function studies and this involves having the patient inhale a dose of gaseous xenon-133, and while the patient holds his breath a scintillation camera is used to take a picture of the patients lungs. This picture shows any portions of the patients lung not functioning or not properly functioning.
  • xenon-I33 in pulmonary function studies has required quantities of xenon in patient dosage sizes accurately measured and readily administered to the patient.
  • devices designed for holding and administering dosage sized quantities of gaseous radioactive xenon to patients have the following requirements, namely ease and safety in administration to the patient; effective radiation shielding during shipment, storage and handling incidental to administration to the patient; a container insuring substantial retention of the radioactive xenon prior to administration to the patient; a container suitable for re-collection of the radioactive xenon after administration to the patient; a system capable of providing multiple administrations to the patient; absence of absorption of the radioactive xenon by the container holding the dosage size quantity of radioactive xenon; and a dispensing device providing high concentration of xenon in one inhalation.
  • One device for holding and administering dosage sized quantities of gaseous radioactive xenon is a Calidose gas dispenser.
  • This dispenser unit is loaded with a glass vial closed off with an elastomeric septum and the glass vial holds the gaseous xenon prior to administration to a patient.
  • the dispenser unit has a manually operated plunger for pushing the septum in the glass vial against two hollow needles and for puncturing the septum.
  • a manually operated rubber squeeze bulb is connected to one hollow needle and flushes the xenon from the glass vial through the other hollow needle into a nozzle and into a breathing apparatus held in the patients mouth.
  • This unit has a portion of the radioactive xenon absorbed by the estomeric septum.
  • a gas cylinder containing radioactive xenon is filled with carbon dioxide to a pressure of three atmospheres giving a xenon-carbon dioxide mixture in the cylinder.
  • a small quantity of the mixture is withdrawn from the cylinder through a micrometer needle valve.
  • the amount of xenonl33 dispensed can be measured by placing the syringe inside a calibrated well-type ionization chamber.
  • Radioactive xenon gas which is to be used in a closed-circuit spirometer system can be taken up into a Hamilton gas-tight syringe for transfer.
  • Another procedure is to use a hypodermic syringe to inject air into an ampoule sealed by a septum containing radioactive xenon and then to withdraw a fraction of the air-xenon mixture.
  • the syringe is exhausted into a closed-circuit spirometer and the patient breathes the gases in the closed-circuit spirometer. This also has the septum absorbing a portion of the radioactive xenon.
  • This dispensing apparatus also called a ventilation study system, has 1) an internal gas-retaining volume, (2) a shearable capsule containing a gaseous radioisotope, (3) valve means holding the capsule within an interior cavity forming a portion of the gas-retaining volume of the ventilation study system, shielding the radioactivity emitted from the radioisotope and being capable of shearing the cap.- sule to release the gaseous radioisotope into the gasretaining volume defined by the system, (4) patient breathing means in communication with the internal cavity of the valve means and a breathing bag defining a portion of the gas-retaining volume of the system and in communication with the internal cavity of the valve means.
  • the shearable capsule is presented in copending U.S. Pat. application Ser. No. 388,700, filed Aug. 15, I973 and is a very important component of this ventilation system.
  • the capsule has a gas impermeable enclosure holding a gaseous radioisotope with one preferred embodiment of the radioisotope being xenon, such as xenon-I33 and xenon-127.
  • the capsule has to be readily shearable by the valve means of the ventilation system covered in co-pending US. Pat. application Ser. No. 388,487, filed Aug. l5, I973 and now abandoned in favor of copending continuation application Ser. No. 549,784, filed Feb.
  • a shearable capsule particularly suitable for use with the ventilation study system disclosed in co-pending US. Pat. application Ser. No. 388,489 is produced by the method of this invention.
  • This invention gives a very reliable, accurate method of producing the shearable capsule with a low unit cost.
  • the method includes the steps of (I) introducing the gaseous radioisotope and the diluent into the mixing zone, (2) mixing the radioisotope and the diluent in the mixing zone, (3) discharging the mixture of (2) into a gas impermeable enclosure, (4) sealing the gas impermeable enclosure into segments of a selected size and (5) separating the segments into individual capsules.
  • An additional step of adding moisture to the gas impermeable enclosure can be practiced along with the filling of the gas impermeable enclosure with the mixture.
  • a particularly preferred gaseous radioisotope is xenon including xenon-l 33 and xenon-I27.
  • a further object of this invention is to provide a method of mixing a radioisotope and a diluent to give a useful radioisotope-diluent mixture and then introducing a selected quantity of this mixture into a gas impermeable enclosure.
  • Another object of this invention is to provide a method of producing a shearable capsule having a gas impermeable enclosure containing a mixture of a gaseous radioisotope, a diluent and moisture with the moisture being provided to eliminate any traces of undesirable gas resulting from radiation degradation of the enclosure.
  • Still another object of this invention is to provide a method of producing a capsule having a gas impermeable enclosure containing a gaseous radioisotope including the steps of introducing a selected amount of the gaseous radioisotope into a mixing zone, introducing a selected amount of a gaseous diluent into the mixing zone, mixing the radioisotope and the diluent in the mixing zone, discharging the radioisotope-diluent mixture into the gas impermeable enclosure sealed on one end, sealing the gas impermeable enclosure into segments of a selected size and separating the segments into individual capsules.
  • FIGS. 1 and 2 present in schematic form two embodi' ments of the apparatus used to produce radioisotope capsules according to the method of this invention.
  • FIG. 1 is adapted to receiving small glass ampoules as the source of the radioisotope and
  • FIG. 2 is adapted to have a large gas cylinder connected to the apparatus as the source of the radioisotope.
  • FIG. 1 there is shown one embodiment of a capsule manufacturing apparatus generally designated by the number 10 for manufacturing capsules containing a gaseous radioisotope.
  • the capsule loading apparatus 10 has a mixing vessel 1 1 serving as a portion of a mixing zone for the gaseous radioisotope and the diluent.
  • the mixing vessel 11 has a movable piston 13 for removing the gas from the mixing vessel 11.
  • a line 12 runs from the mixing vessel 11 to chamber 14, and line 12 has valve 15 and screen 16 (a 200 mesh screen) between chamber 14 and mixing vessel 11.
  • Chamber 14 has a screw piston 17 which can be screwed against the top plate 42 and the bottom of chamber 14.
  • Line 12 further has a screen 18 (a 200 mesh screen), valve 19 and a pressure/vacuum gauge 20 before the junction of line 12 with line 21 which has valve 22.
  • Line 12 further has valve 24 between the connection of line 12 with line 21 and the connection of line 12 with line 25.
  • Evacuation line 25 has two valves 26 and 28 positioned before a pressure gauge 29 and a vacuum pump 30.
  • Line 31 runs between line 25 and a supply 33 of a diluent (e.g. medical grade air) with valve 32 being provided for metering the diluent into line 25.
  • a diluent e.g. medical grade air
  • Line 12 has a 0.45 micron filter 36 before the connection of line 12 with loading line 37.
  • Line 37 is connected with a source 38 of purified water which feeds an automatic pipette syringe 39 for metering the desired quantity of purified water through line 37 and valve 40 into enclosure or tube 41 which is sealed on one end and has the open end of the enclosure 41 connected to line 37.
  • the method of producing a shearable capsule using the apparatus of FIG. 1 will now be described with reference to FIG. 1.
  • the first step involves introducing a selected amount of a gaseous radioisotope and a diluent into a mixing zone and in FIG. 1 the mixing zone is vessel 11 and line 12 up to valve 19.
  • the top plate 42 of the chamber 14 is removed by removing the removable bolts from the top plate 42 on chamber 14 and withdrawing the piston 17.
  • a glass ampoule is placed in the chamber 14 and the ampoule contains a measured quantity of radioisotope, preferably a xenon radioisotope such as xenon-133 and xenon-I27, usually a quantity of about I to about 8 curies.
  • valves 15, 19, 22 and 28 are opened and the vacuum pump 30 is used to pump the portion of lines 25, 21 and 12 thus opened to the pump 30 down to about to about 20 microns pressure as measured on the Hastings pressure gauge 29.
  • valves 28, 22, 19 and are closed, and the screw piston 17 is turned down until the piston 17 comes in contact and crushes the glass ampoule in chamber 14 allowing the radioisotope in the ampoule to expand into the volume defined by the portion of chamber 14 below piston 17 and the portion of line 12 between valves 15 and 19.
  • the screw piston 17 is then raised to the top of chamber 14.
  • a selected amount of a gaseous diluent (e.g. medical grade breathing air) is introduced into the mixing zone.
  • the supply 33 of diluent in line 31 is adjusted to 0.5 psi pressure by closing valve 28 and opening valves 22 along with adjusting a pressure regulator on supply 33 to reach this pressure.
  • the pressure is read on vacuum/pressure gauge which is capable of a reading of super atomospheric and subatmospheric pressure (i.e., pressure greater than atmospheric pressure and pressure less than atmospheric pressure).
  • valve 19 is opened and then closed so that the chamber 14 and the portion of line 12 between valves 15 and 19 is filled with the diluent as well as the radioisotope.
  • valve 15 is opened and the screw piston 17 is screwed down, transferring the radioisotope and diluent to the mixing vessel 11.
  • Valve 15 is closed and screw piston 17 is raised.
  • Valve 19 is opened and closed again to let in further diluent to the portion of line 12 between valves 15 and 19 and chamber 14.
  • Valve 15 is opened to transfer the diluent and any residual radioisotope to mixing vessel 11. This procedure is repeated until the predetermined volume of diluent is introduced with the radioisotope.
  • the quantity of diluent is determined by the final curies of radioisotope desired for the mixture, the number of gas capsules to be made and the concentration of radioisotope per quantity of diluent desired.
  • the next step involves mixing the radioisotope and the diluent in the mixing zone 11 so that a homogeneous mixture is achieved. It is important that the radioisotope and diluent be in the form of a homogeneous mixture. This homogeneous mixture allows accurate aliquoting of premeasured patient doses of the mixture into the gas impermeable enclosure ultimately forming the capsule.
  • the radioisotope is xenon and the diluent is medical grade air
  • the radioisotope and diluent are slow to mix and mechanical agitation is used to expedite this mixing. in FIG. 1 this mixing is acccomplished by raising the screw piston 17 in chamber 14 to the upward most position (against top plate 42) and moving the movable piston 13 in vessel 11 up and down while valve 15 is open and valve 19 is closed.
  • the movement of the radioisotope and diluent between chamber 14 and vessel 11 is sufficient to give a mixing action resulting in a radioisotope-diluent mixture after about 20 cycles with the movable piston 13.
  • the mixture is stored in chamber 14 after the mixing step is complete.
  • the next step involves discharging the mixture of diluent and radioisotope into a gas impermeable enclosure such as an organic material including polyethylene-terephthalate, vinyl-vinylidene chloride and polysulfone. This is done to give test capsules which are used to check the capsules for millicuries of radioisotope per capsule.
  • a portion of the system is evacuated by opening valves 28 and 22 and pump 30 is used to evacuate the system.
  • valves 22 and 28 are closed and the enclosure 41 sealed on one end is placed on the end of line 37 and sealed to line 37 with a Veeco fitting or similar means which makes a temporary seal of the enclosure 41 to line 37.
  • the other end of the enclosure 41 has previously been sealed using a radiofrequency sealer or welder.
  • the enclosure 41 is evacuated to 29 inches mercury by opening valves 26 and 28 and using pump 30 or by using a special mechanical pump that can be attached in a manner to draw on line 37. Valves 19 and 24 are then opened to let the diluentradioisotope mixture into the enclosure 41.
  • the screw piston 17 is then lowered in chamber 14 until the pressure in the chamber 14, line 12 and the enclosure 41 is at a pressure selected from the range of O to 2 psi as indicated on gauge 20. Segments ultimately forming capsules are then sealed at regular intervals, usually at intervals of about 2 inches on the enclosure 41 by using a radiofrequency sealer to seal the enclosure to give a weld with each capsule containing about 1.5cc of the mixture.
  • the thickness of the weld is usually about A to about inch so that the enclosure can then be cut with scissors and the segments become individual capsules about 2 inches in length.
  • the xenon gas capsules are then measured for millicuries of xenon-l 33 per capsule in a gross ionization chamber to perform quality control check on the capsules. This completes the description of the last two steps of the method, namely sealing the gas impermeable enclosure into segments of a selected size and separating the segments into individual capsules.
  • the stub of the enclosure 41 is removed from line 37 after valves 19 and 24 are closed and the production of capsules is commenced as previously done for the test capsules.
  • a long segment of the enclosure (or tube) 41 is used that has been sealed on the end not attached to line 37.
  • the enclosure 41 is evacuated, either by pump 30 or by use of another mechanical pump inserted in line 37 as previously described above.
  • valves 19 and 24 are opened to fill enclosure 41 with the mixture of radioisotope and diluent to a pressure selected from the range of O to 2 psi as indicated on the gauge 20.
  • valve 40 When it is desired to insert a quantity of water such as a droplet of water, valve 40 is opened and about 0.2 to about 0.3 cubic centimeter of water is added by pushing down on the plunger of the automatic pipette syringe 39 which is fed by purified water from source 38.
  • the droplet of water falls to the lower end of the tube 41 and a segment is sealed off at a mark by a radiofrequency sealer, usually to give a two inch segment or capsule as described above.
  • Another 0.2 to 0.3 cubic centimeters of water is added by pushing down on syringe 39 and a second segment is sealed by the radiofrequency sealer.
  • the gas capsules are examined over a light to insure that the water droplet is present in the capsule and that there are no visual defects in the capsule.
  • the gas capsules are placed in a desiccator and evacuated to 25 inches of water for about minutes to evacuate any capsules that are leaking.
  • the gas capsules are then assayed by individually placing the capsule in a radiation detection instrument such as a gross ionization chamber, and the acceptable gas capsules are then sampled for quality control before being prepared for shipment.
  • FIG. 2 presents the apparatus for a method using a gas cylinder for transferring the radioisotope into the enclosure 4! with like numbers being used for the same components presented above in FIG. 1.
  • a gas cylinder 50 is connected with line 12 between the chamber 14 and the mixing vessel 11.
  • An additional valve 54 is provided in line 12 between cylinder 50 and vessel 11 to interrupt flow from the cylinder 50 to vessel 11.
  • Line 51 is provided intersecting line 12 at a point between vessel 11 and valve 54 and at a point between valve 15 and screen 16.
  • Line 51 has valve 52 to control flow through line 51.
  • a U-tube 53 is provided in line 12 along with freezing means 56 (eg, a liquid nitrogen container) to freeze the radioisotope in U-tube 53 after release from cylinder 50.
  • freezing means 56 eg, a liquid nitrogen container
  • the system is evacuated to about to about 20 microns by opening valves 28, 22, l9, 15, 54 and 52 and using pump 30 while leaving valves 24, 26 and 32 closed. Valves 28, 22, l9, I5, 54 and 52 are then closed, and the gas cylinder 50 is opened to the U-tube 53 and the radioisotope is frozen into U-tube 53 by liquid nitrogen in freezing means 56. The cylinder 50 is closed and valve is opened followed by removal of the freezing means 56 from U-tube 53. As the U-tube 53 warms, the radioisotope expands into chamber 14.
  • the diluent is then added from supply 33 by opening valves 32, 22, and 19 to let sufficient diluent into chamber 14 and line 12.
  • the radioisotope and diluent in chamber 14 and line 12 is transferred back and forth through either open valve 52 in line 51 to vessel 1! or through open valve 15, U- tube 53 and open valve 54 to vessel 11 for a suitable number of times to achieve a mixture of the radioisotope-diluent.
  • the radioisotope-diluent mixture is sampled, assayed and put into capsules similar to the procedure described above for FIG. 1.
  • valves 15 and 54 are closed, and cylinder 50 is then replaced.
  • the capsule produced by the practice of this invention is comprised of a shearable, gas impermeable enclosure which contains a gaseous radioisotope useful for medical applications.
  • a gaseous radioisotope useful for medical applications.
  • Various materials meet the gas impermeable requirement of this invention and are capable of being readily sheared to release the gas with representative materials including polyethyleneterephthalate, vinyl-vinylidene chloride and polysulfone.
  • gaseous radioisotopes can be used in the practice of this invention and are sealed in the enclosure of the capsule produced by the practice of this invention.
  • a preferred radioisotope is a xenon radioisotope including xenon-I27, xenon-I33, and xenonl29m.
  • Other gaseous radioisotopes can be used including radon-222 and kyrpton-85. The person skilled in the art will realize that various gaseous radioisotopes can be selected and used depending upon the particular medical application at hand.
  • a diluent with the gaseous radioisotope in the capsule 23 may be desirable to include a diluent with the gaseous radioisotope in the capsule 23.
  • Representative diluents are air. nitrogen, medical grade air or oxygen. Moisture or water vapor or other physiologically benign absorbents for radiolysis products of the capsule enclosure material also may be added.
  • a method of manufacturing a capsule comprising a shearable gas impermeable enclosure having therein a gaseous radioisotope comprising the steps of a. introducing the gaseous radioisotope and a gaseous diluent into a mixing zone,
  • step (b) discharging the mixture of step (b) into a gas impermeable enclosure sealed on one end
  • radioisotope is comprised of krypton-85.
  • a method according to claim 10 further including the additional step of introducing moisture into the enclosure which is a plastic container.
  • a method according to claim 1 in which the en- 16 A method according to claim 1 in which the sealclosure is a plastic container comprised of polysulfone. 5 ing step is conducted by ultrasonic welding.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
US388488A 1973-08-15 1973-08-15 Method of manufacturing capsules containing gaseous radioisotope Expired - Lifetime US3893278A (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
US388488A US3893278A (en) 1973-08-15 1973-08-15 Method of manufacturing capsules containing gaseous radioisotope
AU68518/74A AU479764B2 (en) 1973-08-15 1974-05-02 Method of manufacturing capsules containing gaseous radioisotope
DK249574AA DK134388B (da) 1973-08-15 1974-05-07 Fremgangsmåde til fremstilling af kapsler indeholdende gasformig radioisotop til lungeventilation.
DK29574*#A DK29574A (da) 1973-08-15 1974-05-07
GB2085574A GB1465961A (en) 1973-08-15 1974-05-10 Method of manufacturing capsules containing gaseous radio isotopes
NL7407235A NL7407235A (nl) 1973-08-15 1974-05-29 Werkwijze voor het vervaardigen van een capsule met daarin een gasvormige radioactieve isotoop, alsmede een aldus vervaardigde capsule.
DE2434277A DE2434277A1 (de) 1973-08-15 1974-07-17 Verfahren zum herstellen von kapseln, die gasfoermige radioisotope enthalten
CH1091674A CH573748A5 (da) 1973-08-15 1974-08-09
FR7427942A FR2245336B1 (da) 1973-08-15 1974-08-12
BE147543A BE818776A (fr) 1973-08-15 1974-08-13 Procede de fabrication de capsules contenant un radioisotope gazeux
JP49092430A JPS5072479A (da) 1973-08-15 1974-08-14
IT26304/74A IT1019936B (it) 1973-08-15 1974-08-14 Metodo di fabbricazione di ca psule contenenti radioisotopi gassosi ad uso diagnostico
SE7410389A SE409075B (sv) 1973-08-15 1974-08-14 Saett att framstaella en kapsel innefattande ett klippbart foer gas ogenomtraengligt hoelje med en daeri befintlig gasformig radioisotop

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US388488A US3893278A (en) 1973-08-15 1973-08-15 Method of manufacturing capsules containing gaseous radioisotope

Publications (1)

Publication Number Publication Date
US3893278A true US3893278A (en) 1975-07-08

Family

ID=23534316

Family Applications (1)

Application Number Title Priority Date Filing Date
US388488A Expired - Lifetime US3893278A (en) 1973-08-15 1973-08-15 Method of manufacturing capsules containing gaseous radioisotope

Country Status (11)

Country Link
US (1) US3893278A (da)
JP (1) JPS5072479A (da)
BE (1) BE818776A (da)
CH (1) CH573748A5 (da)
DE (1) DE2434277A1 (da)
DK (2) DK29574A (da)
FR (1) FR2245336B1 (da)
GB (1) GB1465961A (da)
IT (1) IT1019936B (da)
NL (1) NL7407235A (da)
SE (1) SE409075B (da)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001070102A2 (en) * 2000-03-20 2001-09-27 Medi-Physics, Inc. Meted hyperpolarized noble gas dispensing methods and associated devices
US6427452B2 (en) 1998-09-30 2002-08-06 Medi-Physics, Inc. Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers
US6523356B2 (en) 1998-09-30 2003-02-25 Medi-Physics, Inc. Meted hyperpolarized noble gas dispensing methods and associated devices
US20060254668A1 (en) * 2005-05-13 2006-11-16 Hon Hai Precision Industry Co., Ltd. Fluid filling system and method for filling vacuum container
US8069886B1 (en) 2006-06-02 2011-12-06 Vulcan Lead, Inc. Capsule preparation system
US8561282B2 (en) * 2009-02-04 2013-10-22 Nosaka Tec Co., Ltd. Method of coupling container body and cover member
US9340004B2 (en) 2011-10-06 2016-05-17 Bio Capsule Pharmaceutical And Nutritional Products (Pty) Ltd. Method and apparatus for manufacturing a capsule
US9456987B2 (en) 2013-04-03 2016-10-04 Binutra, Inc. Capsule with internal diaphragm
US11186389B2 (en) * 2018-06-14 2021-11-30 Curium Us Llc Evacuation/fill station for radioactive fluid container production

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3040490A (en) * 1960-05-31 1962-06-26 Triangle Package Machinery Co Apparatus and method for making, filling, and sealing containers
US3376688A (en) * 1965-03-27 1968-04-09 Takacs Geza Method and equipment for the automatic preparation of sterile and fibre-free liquid pharmaceutical products of high stability filled in ampoules, in a protective atmosphere

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3040490A (en) * 1960-05-31 1962-06-26 Triangle Package Machinery Co Apparatus and method for making, filling, and sealing containers
US3376688A (en) * 1965-03-27 1968-04-09 Takacs Geza Method and equipment for the automatic preparation of sterile and fibre-free liquid pharmaceutical products of high stability filled in ampoules, in a protective atmosphere

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667008B2 (en) 1998-09-30 2003-12-23 Medi-Physics, Inc. Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers
US6523356B2 (en) 1998-09-30 2003-02-25 Medi-Physics, Inc. Meted hyperpolarized noble gas dispensing methods and associated devices
US6537825B1 (en) 1998-09-30 2003-03-25 Medi-Physics, Inc. Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers
US6543236B2 (en) 1998-09-30 2003-04-08 Medi-Physics, Inc. Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers
US6427452B2 (en) 1998-09-30 2002-08-06 Medi-Physics, Inc. Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers
WO2001070102A2 (en) * 2000-03-20 2001-09-27 Medi-Physics, Inc. Meted hyperpolarized noble gas dispensing methods and associated devices
WO2001070102A3 (en) * 2000-03-20 2003-01-23 Medi Physics Inc Meted hyperpolarized noble gas dispensing methods and associated devices
US7591121B2 (en) * 2005-05-13 2009-09-22 Hon Hai Precision Industry Co., Ltd. Fluid filling system
US20060254668A1 (en) * 2005-05-13 2006-11-16 Hon Hai Precision Industry Co., Ltd. Fluid filling system and method for filling vacuum container
US8069886B1 (en) 2006-06-02 2011-12-06 Vulcan Lead, Inc. Capsule preparation system
US8561282B2 (en) * 2009-02-04 2013-10-22 Nosaka Tec Co., Ltd. Method of coupling container body and cover member
US9340004B2 (en) 2011-10-06 2016-05-17 Bio Capsule Pharmaceutical And Nutritional Products (Pty) Ltd. Method and apparatus for manufacturing a capsule
US10046549B2 (en) 2011-10-06 2018-08-14 Combocap, Inc. Method and apparatus for manufacturing a capsule
US9456987B2 (en) 2013-04-03 2016-10-04 Binutra, Inc. Capsule with internal diaphragm
US11186389B2 (en) * 2018-06-14 2021-11-30 Curium Us Llc Evacuation/fill station for radioactive fluid container production

Also Published As

Publication number Publication date
NL7407235A (nl) 1975-02-18
JPS5072479A (da) 1975-06-16
AU6851874A (en) 1975-11-06
DK29574A (da) 1975-04-21
CH573748A5 (da) 1976-03-31
DK134388C (da) 1977-05-09
FR2245336B1 (da) 1978-04-28
IT1019936B (it) 1977-11-30
DK134388B (da) 1976-11-01
BE818776A (fr) 1975-02-13
SE7410389L (da) 1975-02-17
FR2245336A1 (da) 1975-04-25
SE409075B (sv) 1979-07-30
DE2434277A1 (de) 1975-02-27
GB1465961A (en) 1977-03-02

Similar Documents

Publication Publication Date Title
US4968299A (en) Method and device for injection
US3774036A (en) Generation of a supply of radionuclide
US5039863A (en) Automatic radioisotope filling apparatus
CA2118034C (en) Injection cartridge arrangement
US3893278A (en) Method of manufacturing capsules containing gaseous radioisotope
JP2004535221A (ja) 注射のための放射性薬品を調製するための方法と装置
US4364376A (en) Method and device for injecting a bolus of material into a body
US4241728A (en) Method and apparatus for dispensing radioactive materials
JPS58169452A (ja) 一物質と他物質との混合方法
KR100966281B1 (ko) 방사성 의약품 보존용 컨테이너 및 이 의약품을 환자에게주입하기 위한 배치 구조물
US20030102012A1 (en) Method and system for cleaning and reusing a cannula
JP2005531334A (ja) 放射性医薬カプセル調剤システム
US4192438A (en) Device for delivering radioactive gas from a sealed vial
US3564256A (en) Radioisotope generator of the mother-daughter type having quick-detachable members
US3848773A (en) Radioactive gas dispensing device
US3957033A (en) Ventilation study system
US3926176A (en) Radioactive gas-containing polymeric capsule
Riegelman et al. The kinetics of rectal absorption I. Preliminary investigations into the absorption rate process
WO2017072279A1 (en) Shielding device
DE2343641C2 (de) Vorrichtung zum Einführen eines gasförmigen Radioisotops in einen Patienten, eine Kapsel zur Verwendung in einer derartigen Vorrichtung und eine Einheit zum sicheren Verpacken der Kapsel
US3509919A (en) Production of a pharmaceutically acceptable saline solution containing a radioactive gas and use thereof
JPH05329209A (ja) ポジトロン薬剤注射装置および注射装置の操作方法
Lewis et al. Radioactive xenon solution
BE804323A (fr) Dispositif d'etude de la ventilation
Gutkowski et al. A Calibrated Dose Dispenser for Gaseous 133Xe